Much information regarding the association of the Epstein-Barr virus (EBV) with infectious mononucleosis, Burkitt's lymphoma and nasopharyngeal carcinoma has been derived from serological test procedures, involving a number of distinct antigen-antibody systems related to EBV. These relationships have been recently reviewed (Henle & Henle, 1972).
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Raji cell suspension (3"5 x iO cells/ml) were added to each well (875 cells/well). This cell concentration gave between Ioo and 2oo colonies/well. The plate was incubated for I h at 37 °C and shaken at 15 rain intervals. After the 'virus exposure period' o'I ml of medium was added and the plate was incubated for 4 to 6 days at 37 °C in a humidified atmosphere of 5 % CO2 in air. Results were read under an inverted microscope by counting the colonies present in the wells. The highest dilution of virus, that reduced colony formation by more than 95 %, as compared to uninfected controls, was chosen as the dose employed for neutralization tests. Each colony that grew in the controls was considered to arise from one infectable unit. The concentration of virus causing 50 % inhibition of colony formation was calculated by the method of Reed & Muench (I938) and used for comparison of the effects of different cell-virus ratios on the results of virus titrations.
Titrations of virus by immunofluorescence assays followed the procedure described by Henle, Henle & Klein (I970. The virus samples used showed considerable variations in titres as measured by both assay methods, due to as yet uncontrollable fluctuations in virus production by the HR-I line.
The sera for titration of neutralizing antibodies were selected on the basis of their antibody titres to VCA (Henle & Henle, 1966; Henle et al. t969) to cover a range from very high to negative values (see Table z ). They had been stored at -2o °C and were inactivated at 56 °C for 3o rain before use.
Microtitre equipment (Cook Engineering Co., Alexandria, Virginia) was used for the neutralization test. The sera were diluted in twofold steps in microplates, according to the technique described by Sever 0962), starting with 1:5, and 25 #1 of appropriately diluted virus was added to each well containing 25/d serum dilution. To duplicates of the first three serum dilutions, medium was added instead of virus as a control of serum toxicity. A virus control (no serum) as well as virus titration of several further series o'5 log10 dilutions accompanied each test. The serum-virus mixtures were incubated for I h at 37 °C and the plates shaken every 15 min. Additional overnight incubation at 4 °C was carried out in one test. At the end of the incubation period Raji cells and subsequently medium were added as described for virus titrations. After 4 to 6 days of incubation at 37 °C in an atmosphere of 5 % CO2 in air, the wells were scanned under an inverted microscope and scored for the approximate numbers of colonies. A well showing colonies amounting to > 3o % of the number found in uninfected controls was considered to show evidence of neutralization. After microscopic examination the plates were returned to the CO2 incubator for an additional 4 to 5 days and then incubated at the same temperature in normal atmosphere overnight. At this point virus neutralization was evident also from an acid pH (metabolic activity) as shown by the yellow colour of the indicator (phenol red).
In early experiments cells were exposed to serum-virus mixtures and then seeded in soft agar to observe the effect on colony formation (Rocchi et al. 1973) . It was noted subsequently that agar is not essential as a supporting medium and all neutralization tests were therefore performed in fluid medium. Fig. I shows the sequential growth of uninfected Raji cells over a 4-day period, and the complete abrogation of colony formation after infection with EBV.
In order to determine the minimal dose of virus required for the test, experiments were performed to evaluate the influence of cell-virus ratios on colony formation. Volumes of I ml of serially diluted virus were therefore incubated with I ml volumes of a cell suspension containing 4 × IO4, 4o x IO 4 and 4oo × IO 4 cells/ml, respectively, and incubated at 37 °C for I h. The cell concentrations in the last two sets of preparations were then adjusted to that of the first set (2 x Io4/ml), by dilution with medium and 40 #1 of each preparation was transferred to quadruplicate wells of a micro-plate containing 2 o / d of medium and an additional o.I ml of medium was added to each well before the plates were incubated. The colonies were counted 5 days later as described. Table I shows that with a decrease in the numbers of cells used for infection, the virus titre increases roughly corresponding to the increase in the cell-virus ratio. It was evident that the smallest number of cells needed for f o r m a t i o n of sufficient numbers of colonies in micro-wells (about 9oo cells/well) would be suitable for the neutralization tests. Table 2 presents the results of neutralization tests carried out with ~4 selected sera on five separate occasions and with different virus preparations. There was close agreement a m o n g the five separate tests. The two sera that were negative for anti-VCA in indirect immunofluorescence tests also failed to show neutralizing antibodies. The i2 anti-VCA positive sera all revealed neutralizing activity. The serum of Burkitt the t u m o u r patient, F . M . , and the negative serum from J.H. have been used as standard positive and negative controls in further tests and were examined thus more than 30 times, always giving the same results. IO -2"sl 10 -l'4s 10 3-04 10-2"16 i o--l'Sg * Average number of colonies developing in four wells of a microplate; standard error is given in parentheses.
In most cases the agreement between the microscopic and metabolic readings was close. If there was a discrepancy, the titres obtained by metabolic readings were one dilution step lower than those recorded for microscopic readings. This difference is reflected in the geometric mean titres.
In test number 5 the virus-sermn mixtures were incubated at 37 °C for I h and overnight at 4 °C before adding the cells. With three sera there was a slight indication of an increase in titre, which, however, appeared hardly significant. For each test, different virus preparations were used. While the potency of these lots, as measured by both immunofluorescence and cytopathogenicity assays, varied over a 3o-fold range, this fact had no apparent influence on the neutralizing titres of the sera as long as the dilution of the virus used was properly adjusted.
The method described is apparently both sensitive and reliable for detecting neutralizing antibodies to EBV. The performance of the test is simple and the microtitre method for serum dilution is well accepted for determination of titres for a variety of different antibodies. It permits the screening and titration of large numbers of sera for EBV-neutralizing antibodies. Microscopic reading of the plates is rapid when a dose of virus is used which o/ rather than a dose inhibits cell growth and colony formation in controls by 95 to ~oo /o causing only 50 % inhibition. The clearly negative or clearly positive wells under these conditions need only be scanned, while an actual count of colonies is restricted to those wells near the serum end-point. Reading on the basis of pH changes also depends upon nearly complete inhibition of cell growth so that clearly negative and positive results are evident from the indicator colour. The two methods of evaluation provide an 'internal' check of the results. The selected sera revealed a wide spectrum of neutralizing titres ranging from I : 5 up to 1 • 2560. The reproducibility of these results was good even though in each test different virus preparations of varying potency were used after appropriate dilutions. a Table 2 . ~. Data not used to calculate the geometric mean titre.
EBV neutralization by selected sera. Titres determined by microscopic (mic) and metabolic (met) readings
NT, not tested.
OO
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The neutralization test for EBV differs to a certain extent from neutralization tests used for titration of antibodies against cytopathogenic viruses in permissive cell cultures. Conventionally, the 5o % infective dose of a virus suspension is determined and a multiple of this dose, usually Ioo TCD 5o is used in the neutralization test. Non-neutralized virus, however little, causes a spreading infection with destructive cytopathic effects. In contrast, the infection of Raji cells by EBV is abortive. There are no detectable second cycles of infection and therefore the number of effectively adsorbed infectious virus particles must be at least as great as the number of exposed cells, in order to detect a high degree of colony inhibition. This consideration implies that in this test system, allowing for non-adsorbed virus, probably about I8oo infectious virus particles must be neutralized by the diluted serum. A small non-neutralized fraction would fail to register, since it could reduce colony formation by only an insignificant amount. The sensitivity of this test seems comparable to the conventional type of neutralization test. Any further increase in sensitivity is limited by the cell numbers which must be used to obtain sufficient colonies in the uninfected controls. The number of cells exposed in the conventional test is immaterial.
From the limited number of sera included in this report it seems evident that those without antibodies to VCA are also free of neutralizing antibodies, whereas all sera containing anti-VCA show neutralizing activity. This correlation requires confirmation by testing additional sera. The ratios between neutralizing antibody and anti-VCA titres of single sera varied, however, over an eightfold range, indicating that different antigens are involved in the two systems, as was noted also by Pearson et al. (~97o) . Comparative studies on the antibody levels to various EBV-related antigens and neutralizing titres are in progress which at the same time are intended to determine the distribution of neutralizing antibodies in populations at large as well as in the various EBV-associated diseases.
